相关实验视频
Updated: May 10, 2025

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.3K
微RNA-26b可以保护小鼠免受MASH的发展,并且可以通过脂质纳米颗粒有效地向
Linsey Peters1,2,3,4, Leonida Rakateli1,2, Rosanna Huchzermeier1,2
1Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.
eLife
|April 22, 2025
概括
微RNA-26b缺乏症通过增加脂质和炎症加剧代谢功能障碍相关的脂肪肝炎 (MASH). 脂质纳米粒子治疗有效地在小鼠和人类肝脏模型中拯救了MASH表型.
科学领域:
- 肝病学和分子生物学.
- 生物技术和药物输送
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 患病率正在上升,需要对其机制进行研究.
- 微RNA-26b (Mir26b) 涉及与MASH病变发生相关的途径.
研究的目的:
- 调查Mir26b在MASH发育中的作用.
- 为了评估Mir26b模仿载荷脂质纳米粒子 (LNPs) 对MASH的治疗潜力.
主要方法:
- 使用的Apoe-/-Mir26b-/-和Apoe-/-Lyz2creMir26bfl/fl小鼠被用西方类型的饮食养为MASH模型.
- 用Mir26b模仿载荷的LNP来拯救MASH表型.
- 在人类精密切割肝脏切片和采用酶分析的验证结果.
主要成果:
- Mir26b缺乏导致肝脂增加,炎症 (TNF,IL-6),巨细胞透和纤维化 (Tgfb表达).
- 经过LNP治疗,可以逆转肝脂积累和炎症信号.
- Mir26b模仿载荷的LNP在人类肝脏模型中减少了炎症.
结论:
- 缺少Mir26b对MASH的发病有重大影响.
- 基于LNP的Mir26b模仿剂提供了对MASH的有前途的治疗策略.
- 这项研究为MASH机制和潜在的基于LNP的治疗提供了新的见解.
相关概念视频
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K

